Discover

MIRA
MIRA Pharmaceuticals, Inc.
0.95
2 x 0.67
2 x 1.22
bid
ask
+
0.00
0.08%
2 @ 04:51 AM
0.92 -0.03 (2.88%)
Ytd-37.26%
1y-21.71%
0.92
day range
0.96
0.90
52 week range
2.45
Open0.96Prev Close0.95Low0.92High0.96Mkt Cap39.81M
Vol31.85KAvg Vol123.62KEPS-1.27P/EN/AForward P/E-2.14
BetaN/AShort Ratio0.47Inst. Own5.96%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg1.00200-d Avg1.251yr Est12.08
Income Statement
Operating Expenses1.10M
Research and Development Expense524.78K
Selling, General and Administrative Expense578.70K
Operating Income-1.10M
Net Income-1.15M
Net Income Common Stock-1.15M
Net Income Common Stock (USD)-1.15M
Consolidated Income-1.15M
Earnings per Basic Share-0.03
Earnings per Basic Share (USD)-0.03
Earnings per Diluted Share-0.03
Earning Before Interest & Taxes (EBIT)-1.15M
Earning Before Interest & Taxes (USD)-1.15M
Weighted Average Shares41.94M
Weighted Average Shares Diluted41.94M
Balance Sheet
Cash and Equivalents4.82M
Cash and Equivalents (USD)4.82M
Investments4.59M
Investments Current4.59M
Trade and Non-Trade Receivables35.44K
Current Assets9.43M
Total Assets9.46M
Current Liabilities114.76K
Total Liabilities114.76K
Accumulated Retained Earnings (Deficit)-40.73M
Shareholders Equity9.35M
Shareholders Equity (USD)9.35M
Assets Non-Current35.44K
Trade and Non-Trade Payables34.01K
Cash Flow
Net Cash Flow from Financing-330.61K
Net Cash Flow / Change in Cash & Cash Equivalents-1.53M
Issuance (Repayment) of Debt Securities -330.61K
Net Cash Flow from Operations-1.20M
Share Based Compensation107.59K